Relenza (ZANAMIVIR)
Ended Awarded Last action
- Contract number
- HSHQDC10J00339
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
Office of Procurement Operations
Department of Homeland Security
- Obligated
- $2,085
Award facts
- Opportunity
-
- HSHQDC10R00016 Solicitation number
- Antiviral Medicine Zanamivir (trade name Relenza) Award Notice · Posted Jan 7, 2010
- Contract value 100% obligated
- $2,085.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20005, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,085 |
Quick answers
Who was awarded contract HSHQDC10J00339?
HSHQDC10J00339 was awarded to Glaxosmithkline Holdings (Americas) Inc. by Office of Procurement Operations (Department of Homeland Security) on July 19, 2010.
How much is contract HSHQDC10J00339 worth?
The government has obligated $2,085 on HSHQDC10J00339.
Is contract HSHQDC10J00339 an order under another contract?
Yes. HSHQDC10J00339 is a delivery order under HSHQDC10D00025, an indefinite delivery contract.
Was contract HSHQDC10J00339 competed?
The extent of competition for HSHQDC10J00339 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award